Jennifer J. Rhodes

Senior Vice President & General Counsel at Angion Biomedica Corp.

Jennifer J. Rhodes

Jennifer J. Rhodes

Senior Vice President & General Counsel at Angion Biomedica Corp.

Overview
Career Highlights

Angion Biomedica Corp.
Adamas Pharmaceuticals, Inc.
Medivation LLC (California)

RelSci Relationships

3901

Number of Boards

1

Birthday

1971

Age

50

Contact Data
Trying to get in touch with Jennifer J. Rhodes? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Jennifer J. Rhodes likely has professional access to. A relationship does not necessarily indicate a personal connection.

President, Chief Executive Officer & Director at Angion Biomedica Corp.

Relationship likelihood: Strong

Executive Chairman of the Board & Chief Scientific Officer at Angion Biomedica Corp.

Relationship likelihood: Strong

Founder at Adamas Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Adamas Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Chief Accounting Officer at Adamas Pharmaceuticals, Inc.

Relationship likelihood: Strong

Former Director & Vice President at Angion Biomedica Corp.

Relationship likelihood: Strong

Chief Commercial Officer at Adamas Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Medical Officer at Adamas Pharmaceuticals, Inc.

Relationship likelihood: Strong

Partner, San Francisco at Cooley LLP

Relationship likelihood: Strong

Of Counsel at Cooley LLP

Relationship likelihood: Strong

Paths to Jennifer J. Rhodes
Potential Connections via
Relationship Science
You
Jennifer J. Rhodes
Senior Vice President & General Counsel at Angion Biomedica Corp.
Education
J.D

Wake Forest Law evolved as a small Baptist college for men located just north of Raleigh, North Carolina, to an independent, multi-dimensional, nationally recognized university located in Winston-Salem. Wake Forest Law has grown along with and at times led the development of the institution of which it is a part. The law school, which has worked to meet the needs of a changing legal profession as well as the changing needs of students, continues to be a leader in legal education.

B.A. in Economics

Newcomb–Tulane College, located in New Orleans in the U.S. state of Louisiana, is the academic home for all of Tulane University's full-time undergraduate students. The College was founded in 2005 to maximize Tulane's use of resources by combining the administrative functions of the all-male Tulane College with the administrative functions of the all-female H. Sophie Newcomb Memorial College.

Career History
Senior Vice President & General Counsel
2020 - Current

Angion Biomedica Corp. operates as a biopharmaceutical company. It focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 06, 1998 and is headquartered in Uniondale, NY.

Chief Business Officer, General Counsel, Chief Compliance Officer & Corporate Secretary
2016 - 2020

Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA.

Secretary, General Counsel & Compliance Officer
2012 - 2015

Medivation blends a unique business model with an expert team to bring promising medical technologies from the lab bench to the patient bedside. Our enzalutamide (formerly MDV3100) clinical development program addresses a large market with significant unmet medical needs. Medivation was founded by a group of experienced professionals with a long track record of working together successfully as a team in the pharmaceutical, biotechnology and medical device industries. We founded Medivation to leverage that expertise to bridge the medical product development gap between early-stage development and product launch. Through our extensive network of contacts with top-flight scientists and research institutions, we acquire early-development stage pharmaceuticals and medical devices that have promising clinical, intellectual property and commercial prospects. Using the extensive development experience and expertise of our core team, supplemented by expert consultants in relevant functions, we identify and execute the strategic pathway that will allow the most rapid, efficient and effective development. ?Our business strategy is straightforward: Build a portfolio of four to six product candidates that have the potential to be in clinical development within 12 to 18 months after acquisition; clinical studies and commercialization or, depending on the indication, conduct those activities internally. Develop those product candidates as rapidly and efficiently as possible; and Consider partnering or selling successful programs to large pharmaceutical, biotechnology or medical device companies for late-stage clinical studies and commercialization or, depending upon the indication, conduct those activities internally. Our enzalutamide development program addresses a large market with significant unmet medical needs.

Transactions
Details Hidden

Adamas Pharmaceuticals, Inc. issued USD Common Stock

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jennifer J. Rhodes. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jennifer J. Rhodes's profile does not indicate a business or promotional relationship of any kind between RelSci and Jennifer J. Rhodes.